In patients with high tTMB, objective responses occurred across four tumor types: urothelial carcinoma (UC; bladder cancer), endometrial, melanoma, or NSCLC; the nonresponsive tumor types comprised only 9 patients. This evidence concerns the gene TMEM200B and melanoma.